Teva confirms efficacy in late-stage trial of its migraine treatment for adult Chinese patients
https://seekingalpha.com/news/4088897-teva-confirms-efficacy-in-late-stage-trial-of-its-migraine-treatment-for-adult-chinese-patients?source=feed_tag_israel
Apr 11, 2024 - Late-stage study confirms efficacy and safety of Teva Pharmaceutical's AJOVY in preventing migraines in adult Chinese patients.
0
Teva analysis shows migraine drug as effective in obese patients as non-obese
https://seekingalpha.com/news/4044016-teva-analysis-shows-migraine-drug-as-effective-in-obese-patients-as-non-obese?source=feed_sector_healthcare
Dec 06, 2023 - Teva Pharmaceutical Industries (TEVA) said that its drug Ajovy was found to be as effective in reducing migraine attacks in obese patients as non-obese. Read more here.
0
Piper Sandler raises Teva to neutral, stock up 4%
https://seekingalpha.com/news/4052045-piper-sandler-raises-teva-to-neutral-stock-climbs?source=feed_sector_healthcare
Jan 03, 2024 - Piper Sandler has upgraded Teva (TEVA) to neutral, citing the company’s efforts to lower its debt and “lean into its brand assets." The investment bank added, h
0
Teva Pharmaceutical Industries Limited (TEVA) Presents at J.P. Morgan 42nd Annual Global Healthcare Conference (Transcript)
https://seekingalpha.com/article/4661970-teva-pharmaceutical-industries-limited-teva-presents-j-p-morgan-42nd-annual-global-healthcare?source=feed_tag_israel
Jan 09, 2024 - Teva Pharmaceutical Industries Limited (NYSE:NYSE:TEVA) J.P.
0
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/01/31/teva-pharmaceutical-industries-teva-q4-2023-earnin/?source=iedfolrf0000001
Jan 31, 2024 - TEVA earnings call for the period ending December 31, 2023.
0
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4666377-teva-pharmaceutical-industries-teva-q4-2023-earnings-call-transcript?source=feed_tag_israel
Jan 31, 2024 - Teva Pharmaceutical Industries Limited (NYSE:NYSE:TEVA) Q4 2023 Earnings Conference Call January 31, 2024 8:00 AM ETCompany ParticipantsRichard Francis -...
0
Teva Pharmaceutical Non-GAAP EPS of $1.00 beats by $0.24, revenue of $4.46B beats by $450M
https://seekingalpha.com/news/4060531-teva-pharmaceutical-non-gaap-eps-of-1_00-beats-0_24-revenue-of-4_46b-beats-450m?source=feed_tag_israel
Jan 31, 2024 - Teva Pharmaceutical reports strong Q4 earnings, exceeding expectations.
0
Teva hits 52-week high on outlook, API divestment
https://seekingalpha.com/news/4060755-teva-stock-hits-52-week-high-outlook?source=feed_tag_israel
Jan 31, 2024 - Teva Pharmaceutical (TEVA) reached a new 52-week high after beating Q4 2023 forecasts and announcing plans to divest its API business. Read more here.
0
Teva earnings preview: Israeli drugmaker to report early Wednesday
https://seekingalpha.com/news/4060267-teva-earnings-preview-israeli-drugmaker-to-report-early-wednesday?source=feed_tag_israel
Jan 30, 2024 - Teva Pharmaceutical Industries (TEVA) is expected to report higher Q4 earnings before market open on Wednesday, with investors looking to see if the Israeli dru
0
Teva to divest API unit to focus on core business strengths
https://seekingalpha.com/news/4060502-teva-to-divest-api-unit-to-focus-on-core-business-strengths?source=feed_tag_israel
Jan 31, 2024 - Teva plans to divest its API business as part of its growth strategy, aiming to focus on core strengths and capitalize on opportunities in the global API...
0